Pages that link to "Q43624578"
Jump to navigation
Jump to search
The following pages link to Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial (Q43624578):
Displaying 28 items.
- Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases (Q24201127) (← links)
- Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases (Q24242944) (← links)
- Omega 3 fatty acids for prevention and treatment of cardiovascular disease (Q24245810) (← links)
- Is complementary and alternative medicine (CAM) cost-effective? A systematic review. (Q24816198) (← links)
- Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults (Q26746461) (← links)
- Investigating the Generalizability of Economic Evaluations Conducted in Italy: A Critical Review (Q26795684) (← links)
- A Comparative Overview of Prescription Omega-3 Fatty Acid Products (Q28972330) (← links)
- Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association (Q30501645) (← links)
- Red blood cell docosahexaenoic acid and eicosapentaenoic acid concentrations are positively associated with socioeconomic status in patients with established coronary artery disease: data from the Heart and Soul Study (Q31156096) (← links)
- Cost effectiveness of natural health products: a systematic review of randomized clinical trials (Q33379761) (← links)
- Fish consumption, blood docosahexaenoic acid and chronic diseases in Chinese rural populations. (Q34267641) (← links)
- The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease (Q35185145) (← links)
- Economic analysis of nutrition interventions for chronic disease prevention: methods, research, and policy (Q35205894) (← links)
- Are complementary therapies and integrative care cost-effective? A systematic review of economic evaluations (Q36220093) (← links)
- Overview of omega-3 Fatty Acid therapies (Q37419411) (← links)
- Complementary/Alternative Medicine in the context of prevention of disease and maintenance of health (Q37493627) (← links)
- Oxidative stress and cardiovascular disease: novel tools give (free) radical insight (Q37501271) (← links)
- Use of number needed to treat in cost-effectiveness analyses (Q38086820) (← links)
- A review of economic evaluations for beneficial health outcomes of micronutrient and long-chain omega-3 fatty acid supplementation (Q38612839) (← links)
- Health economic evaluation of controlled and maintained physical exercise in the prevention of cardiovascular and other prosperity diseases (Q49037111) (← links)
- A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction (Q50786839) (← links)
- Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. (Q55053962) (← links)
- Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease (Q55919856) (← links)
- Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease (Q57689012) (← links)
- Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease (Q89958068) (← links)
- Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease (Q90307768) (← links)
- Cardioprotective effect of indirubin in experimentally induced myocardial infarction in wistar rats (Q92839749) (← links)
- Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease (Q93360900) (← links)